Documente Academic
Documente Profesional
Documente Cultură
Introduction
This section of the course presents concepts in the epidemiology and prevention of disease
transmission in the health care setting. Upon completion of this module, the learner will be able
to:
• Describe how pathogenic organisms may be spread in the health care setting;
• Identify the factors which influence susceptibility to infection;
• Define strategies to reduce the transmission of pathogenic organisms;
• Describe how infection control concepts are applied in practice.
The Chain of Infection is the epidemiologic model most commonly used to describe the spread
of infection in the health care setting. According to this model, infection can only develop when
specific elements are in place. These elements are represented as distinct links in a chain. The
elimination of any one link or factor will prevent infection from taking place. This circumstance
is referred to as a “break in the chain of infection.”
Transmission of infectious agents requires a source (or reservoir) of infectious agents with a
portal of exit; a susceptible host with a portal of entry receptive to the agent; and a mode of
transmission for the agent.
Sources of infectious agents
Causative agents of disease include bacteria, viruses, fungi, parasites and prions. In the health
care setting, infectious agents derive primarily from human sources, but parts of the inanimate
environment may also be a source of transmission.
Human reservoirs include patients, health care personnel, household members and visitors. Such
source individuals may be symptomatic with obvious signs of active infection; or may be
asymptomatic as is seen in subclinical cases and in carriers. Symptoms are not always present
during the incubation period of an infectious disease. Also, individuals may be transiently or
chronically colonized with pathogenic microorganisms, particularly in the respiratory and
gastrointestinal tracts.
Health care providers should be alert to patients with signs and symptoms of communicable
diseases that are prevalent in their community. Diagnostic testing is recommended to confirm
infection in persons who may be asymptomatic carriers of potentially transmissible disease.
Antimicrobial agents, used when appropriate to treat cases of infection, can eliminate the
reservoir and prevent the spread of infection.
In addition to treating patients with communicable disease, environmental controls, such as
proper ventilation, should be in place for any facility that may treat patients with airborne
infections (e.g., tuberculosis). It is important to consider the safety of both health care providers
and patients when populations at risk for airborne diseases are present. Proper environmental
controls can reduce the spread of infection from reservoirs.
Susceptible Host
Infection is the result of a complex interrelationship between a potential host and an infectious
agent. The immune state at the time of exposure to an infectious agent, interaction between
pathogens, and virulence factors intrinsic to the agent are important predictors of an individual’s
outcome.
There is a spectrum of possible outcomes following exposure to an infectious agent. Some
persons exposed to pathogenic microorganisms never develop symptomatic disease while others
become severely ill and even die. Some individuals are prone to becoming transiently or
permanently colonized but remain asymptomatic. Still others progress from colonization to
symptomatic disease either immediately following exposure, or after a period of asymptomatic
colonization.
Host-specific factors that affect immunity and influence the potential for infection include:
Extremes of age: Newborns and the elderly are more susceptible to disease/infection than the
general population.
Presence of underlying disease/infection: Disease which directly impacts the immune system
(e.g., cancer, autoimmune disorder) will markedly reduce an individual’s resistance to
pathogenic organisms. In general, persons weakened by the presence of any disease/infection
will be more susceptible.
Lifestyle: Personal habits may impact susceptibility to communicable diseases. For example,
alcoholics are more susceptible to pneumonia caused by organisms such as Mycobacterium
tuberculosis or Klebsiella pneumoniae. At the same time, healthy behavior (such as regular
exercise) will increase resistance to disease.
Nutritional status: Poor nutrition will weaken the immune system, thereby increasing
susceptibility to disease. Alternatively, good nutrition will strengthen the immune system,
thereby enhancing the ability to ward off disease.
Natural and Passive immunity: Natural immunity to a disease (e.g., chicken pox) may be
acquired as a result of the development of antibodies which follows infection with the causative
agent. The existence of these antibodies will prevent recurrence of a specific disease. Active
immunization (e.g., through vaccination or toxoid administration) and passive immunization
(e.g., through immune globulin or antitoxin administration) also play an important role in the
prevention of communicable disease.
Trauma and Invasive or Surgical procedures: These factors serve to compromise the integrity
of the body’s natural barriers to disease resulting in an increased susceptibility to infection.
Medications: Certain medications (e.g., antimicrobial agents, gastric acid suppressants,
corticosteroids, antirejection drugs, antineoplastic agents, and immunosuppressive drugs)
directly affect the body’s immune system and may increase susceptibility to disease. Long-term
antibiotic treatment can disrupt the body’s normal flora and result in increased susceptibility to
antibiotic-resistant organisms.
Indwelling devices: Synthetic implants and patient care devices such as urinary catheters,
endotracheal tubes, central venous and arterial catheters facilitate development of infection by
allowing potential pathogens to bypass local defenses that would ordinarily impede their
invasion and by providing surfaces for development of “biofilms” that may facilitate adherence
and growth of microorganisms.
Modes of Transmission
The modes of transmission vary by type of organism. Some are transmitted primarily by direct or
indirect contact, (e.g., Herpes simplex virus, respiratory syncytial virus, Staphylococcus aureus);
and others by the droplet (e.g., influenza virus, B. pertussis) or airborne routes (e.g., M.
tuberculosis). Other infectious agents, such as bloodborne viruses (e.g., hepatitis B and C viruses
and HIV) are transmitted rarely in health care settings, via percutaneous or mucous membrane
exposure. Not all infectious agents are transmitted from person to person and some infectious
agents may be transmitted by more than one route.
(1) Contact transmission is the most common mode of transmission. It is divided into two
subgroups: direct contact and indirect contact.
Direct contact transmission occurs when microorganisms are transferred from one infected
person to another person without a contaminated intermediate object or person. Examples of
direct contact transmission between patients and health care personnel include:
• The blood from a patient directly enters a caregiver’s Herpetic Whitlow
body through contact with a mucous membrane or
breaks (i.e., cuts, abrasions) in the skin.
• Mites from a scabies-infested patient are transferred to
the skin of a caregiver while he/she is having direct
ungloved contact with the patient’s skin.
• A health care provider develops herpetic whitlow on a
finger after contact with Herpes simplex virus (HSV)
when providing oral care to a patient without using
gloves, or HSV is transmitted to a patient from a
herpetic whitlow on an ungloved hand of a health care
worker.
(2) Droplet transmission occurs when respiratory droplets carrying infectious pathogens
transmit infection as they travel directly from the respiratory tract of the infectious individual to
susceptible mucosal surfaces of the recipient. Droplets are generated when an infected person
coughs, sneezes, or talks; or during procedures such as suctioning, endotracheal intubation,
cough induction, and cardiopulmonary resuscitation. The distance that droplets travel depends on
the velocity and mechanism by which respiratory droplets are propelled from the source, the
density of respiratory secretions, environmental factors such as temperature and humidity, and
the ability of the pathogen to maintain infectivity over that distance. Based on these
considerations, it may be prudent to don a mask when within 6 to 10 feet of the patient,
especially when exposure to emerging or highly virulent pathogens is likely. Examples of
infectious agents that are transmitted via the droplet route include Bordetella pertussis, influenza
virus, adenovirus, rhinovirus, Mycoplasma pneumoniae, SARS-associated coronavirus, group A
streptococcus, and Neisseria meningitides.
(3) Airborne transmission occurs by dissemination of either airborne droplet nuclei or small
particles in the respirable size range containing infectious agents that remain infective over time
and distance. Microorganisms carried in this manner may be dispersed over long distances by air
currents and may be inhaled by susceptible individuals who have not had face-to-face contact
with (or been in the same room with) the infectious individual. Preventing the spread of
pathogens that are transmitted by the airborne route requires the use of special air handling and
ventilation systems (e.g., Airborne Infection Isolation Rooms or ‘AIIR’) to contain and then
safely remove the infectious agent. Infectious agents to which this applies include
Mycobacterium tuberculosis, rubeola virus (measles), and varicella-zoster virus (chickenpox).
Variola virus (smallpox) is known to be transmitted via droplet and contact routes; however,
published data suggest that this virus may remain airborne over long distances under unusual
circumstances and AIIRs are recommended for housing suspected cases. In addition to AIIRs,
respiratory protection with NIOSH certified N95 or higher level respirator is recommended for
health care personnel entering the AIIR to prevent acquisition of airborne infectious agents such
as M. tuberculosis.
Throughout this curriculum, methods for controlling the transmission of pathogenic organisms
will be discussed. Proper hand washing, proper use of personal protective equipment,
management of patients with communicable diseases, and techniques for sterilization /
disinfection will all be explained in greater detail.
Other types of transmission
Transmission of infection from sources other than infectious individuals includes those
associated with common environmental sources or vehicles such as contaminated food, water, or
medications (e.g., intravenous fluids). Vectorborne transmission of infectious agents from
mosquitoes, flies, rats, and other vermin also can occur but are not a major consideration in
health care settings in the United States.
What is the single most important measure in breaking the chain of infection?
Hand hygiene: Contact with the hands of health care workers is the primary cause of patient
exposure to pathogenic organisms. Proper hand hygiene is the most effective way to reduce the
spread of infection to patients and to other health care workers.
What is the proper way to wash the hands?
Hand washing instructions: Wet the hands with warm running water. Apply soap and work up a
lather for 10 - 15 seconds, while rubbing all surfaces of the hands. Pay close attention to washing
between fingers, around nail beds, and underneath the nails. Duration of washing is important to
assure mechanical removal of debris and allow antimicrobial solutions sufficient contact time to
achieve the desired effect.
After washing the hands, use a paper towel to turn off the water tap. Do not touch the water tap
with freshly washed hands as this will result in re-contamination of the skin. Many health care
facility basins are equipped with wrist blades, foot pedals, or automatic water flow sensors. Such
devices provide more sanitary water delivery.
Health care workers with long fingernails need to be especially careful about proper hand
washing, since microorganisms can live beneath the nails. Artificial nails and chipped nail polish
support the growth of large numbers of bacteria and should be avoided. Natural nails should be
less than one quarter of an inch in length. This is particularly important for providers that have
regular contact with patients at high risk of acquiring infections, e.g., patients in intensive care
units or in transplant units.
Hands should be decontaminated:
• when visibly soiled with blood or other body fluids.
• before having direct contact with patients.
• before donning sterile gloves for placement of a central intravascular catheter.
• before inserting indwelling urinary catheters, peripheral vascular catheters, or other
similar invasive devices.
• after contact with a patient's intact skin (e.g., when taking a pulse or blood pressure, and
lifting a patient).
• after contact with body fluids or excretions, mucous membranes, nonintact skin, and
wound dressings if hands are not visibly soiled.
• if moving from a contaminated-body site to a clean-body site during patient care.
• after contact with inanimate objects (including medical equipment) in the immediate
vicinity of a patient.
• after removing gloves.
• before eating and after using a restroom.
What kind of soap should be used to wash the hands?
Health care facilities can choose from an array of soap products on the market. Given the wide
variety available, the selection of the proper soap requires careful consideration. Staff acceptance
of the product is the most important concern. If staff do not like the soap, they are less inclined to
use it. Cost-effectiveness is another important consideration.
Antimicrobial soaps (e.g., chlorhexidine gluconate, PCMX, iodophors) should be available in
areas where invasive procedures are performed. Such soaps should also be used in special care
units and in areas that house patients infected with antibiotic-resistant organisms. Standard soap
is acceptable for use in visitor areas or areas where patient care does not require direct contact
with body fluids.
If bar soap is used, it should be placed on racks that allow for adequate water drainage. Pools of
water, which accumulate around bars of soap, can be reservoirs for pathogenic organisms (e.g.,
bacteria).
Dispensers used for liquid soap should be checked for caking around the delivery spout. Soap
residue that accumulates around the dispenser can also be a reservoir for infectious agents.
Liquid soap should not be added to a partially empty soap dispenser. This practice of "topping
off" dispensers can lead to bacterial contamination of soap.
Waterless alcohol-based antiseptic hand gels have grown in popularity because they may
conveniently placed in areas of a health facility where sinks and plumbing are not present.
Recent research has shown that these formulations can be more effective than antimicrobial soap
in reducing bacterial counts on the hands of health care workers thereby preventing the
transmission of potentially harmful bacteria between workers and patients. Some studies have
demonstrated that skin dryness caused by alcohol-based solutions is equivalent to or less severe
than dryness caused by standard antiseptic hand washing solutions.
There are several important considerations before implementing an alcohol-based hand washing
system.
• Alcohol-based solutions are flammable and should be stored appropriately.
• Alcohol-based formulations vary in consistency, fragrance, skin conditioning agents, and
drying time. These factors may influence staff acceptance and use of the product.
• Similar to other hand washing products, dispenser systems vary and may be prone to
problems such as clogging.
• Alcohol-based gels and rinses may be more expensive than other types of antiseptic hand
washing solutions.
When using an alcohol-based handrub, apply the product to the palm of one hand and rub
both hands together, covering all surfaces of hands and fingers, until hands are dry. Note
that the volume needed to reduce the number of bacteria on hands varies by product.
Hands that are visibly dirty or contaminated with proteinaceous material, blood or body
fluids, should be thoroughly washed with soap and water. Waterless alcohol-based hand
washing agents are not recommended for hand hygiene in this circumstance.
None of the currently available antimicrobial agents used in antiseptic handwash or antiseptic
hand-rub preparations are capable of killing spore-forming bacteria such as Clostridium difficile
or Bacillus anthracis (anthrax). When caring for patients with C. difficile associated diarrhea,
health care workers should wash hands with soap and water to physically remove spores from
the surface of contaminated hands. Persons with suspected or documented exposure to B.
anthracis-contaminated items also should be encouraged to wash their hands with soap and
water.
Before implementing any new system of hand washing, it is good practice to have staff perform
a thorough evaluation of the product. Staff acceptance will facilitate compliance with hand
washing protocols.
The most recent expert guidelines and materials to promote hand hygiene in a health care facility
may be found on the CDC website at the following address: http://www.cdc.gov/handhygiene/.
What else can a health care worker do to break the chain of infection?
Standard Precautions combine the major features of Universal Precautions and Body
Substance Isolation and are based on the principle that all blood, body fluids, secretions,
excretions (except sweat), non-intact skin, and mucous membranes may contain transmissible
infectious agents. It constitutes the primary strategy for the prevention of health care-associated
transmission of infectious agents among patients and health care personnel.
Standard Precautions include a group of infection prevention practices that apply to all patients,
regardless of suspected or confirmed infection status, in any setting in which health care is
delivered. These practices include: hand hygiene; use of gloves, gown, mask, eye protection, or
face shield, depending on the anticipated exposure; and safe injection practices. Also, equipment
or items in the patient environment likely to have been contaminated with infectious body fluids
must be handled in a manner to prevent transmission of infectious agents (e.g. wear gloves for
direct contact with heavily soiled equipment; properly clean and disinfect or sterilize reusable
equipment before use on another patient).
Transmission-Based Precautions are for patients who are known or suspected to be infected or
colonized with infectious agents (including multiple drug resistant organisms) which require
control measures in addition to Standard Precautions to effectively prevent transmission. Since
the infecting agent may not be known at the time of admission to a health care facility,
Transmission-Based Precautions should be applied based on the clinical syndrome and the likely
etiologic agents. When the pathogen is identified or the infectious etiology is ruled out,
precautions are modified accordingly.
There are three categories of Transmission-Based Precautions: Contact Precautions, Droplet
Precautions, and Airborne Precautions. For diseases that have multiple routes of transmission
(e.g., SARS), more than one Transmission-Based Precautions category may be used. When used
either singly or in combination, they are always used in addition to Standard Precautions.
Contact Precautions are intended to prevent transmission of infectious agents which are spread
by direct or indirect contact with the patient or the patient’s environment; and where the presence
of excessive wound drainage, fecal incontinence, or other discharges from the body suggest an
increased potential for extensive environmental contamination and risk of transmission. Contact
Precautions is the category of isolation most frequently applied when patients are found to have
“epidemiologically important” pathogens that are resistant to first line therapies, have a
propensity for transmission and are associated with serious clinical disease. This includes MRSA
(Methicillin Resistant Staph aureus), VRE (Vancomycin Resistant Enterococcus species), and
Clostridium difficile.
A single-patient room is preferred for patients who require Contact Precautions. When a single-
patient room is not available, consultation with an infection control specialist is recommended to
assess the feasibility and risks associated with other options such as cohorting or keeping the
patient with an existing roommate. Personnel caring for patients on Contact Precautions should
wear a gown and gloves for all interactions that may involve contact with the patient or
potentially contaminated areas in the patient’s environment.
Droplet Precautions are intended to prevent transmission of pathogens spread through close
respiratory or mucous membrane contact with respiratory secretions. Because these pathogens do
not remain infectious over long distances in a health care facility, special air handling and
ventilation are not required to prevent droplet transmission. Infectious agents for which Droplet
Precautions are indicated include B. pertussis, influenza virus, adenovirus, rhinovirus, N.
meningitides, and group A streptococcus (for the first 24 hours of antimicrobial therapy). A
single patient room is preferred for patients who require Droplet Precautions. When a single-
patient room is not available, consultation with an infection control specialist is recommended to
assess the feasibility and risks associated with other options such as cohorting or keeping the
patient with an existing roommate. Health care personnel should wear a mask (a respirator is not
necessary) for close contact with infectious patient; the mask is generally donned upon room
entry.
Airborne Precautions prevent transmission of infectious agents that remain infectious over long
distances when suspended in the air (e.g., rubeola virus [measles], varicella virus [chickenpox],
M. tuberculosis, and possibly SARS-CoV). The preferred placement for patients who require
Airborne Precautions is in an airborne infection isolation room (AIIR). An AIIR is a single-
patient room that is equipped with special air handling and ventilation capacity. In settings with
limited isolation options such as physician offices, masking the patient, placing the patient in a
private examination room with the door closed, and providing respirators or masks to all staff
will reduce the likelihood of airborne transmission until the patient is either transferred to a
facility with an AIIR or returned to the home environment, as deemed medically appropriate.
Health care personnel caring for patients on Airborne Precautions should wear a mask or
respirator prior to room entry. Whenever possible, non-immune workers should not care for
patients with vaccine-preventable airborne diseases (e.g., measles, chickenpox, and smallpox).
Other important measures for reducing the risk of disease transmission include:
• Environmental control measures such as effective housekeeping procedures; appropriate
ventilation; safe handling of visibly contaminated linen and potentially infectious waste.
• Implementation of safe medical devices and safe patient care practices.
• Assuring worker and patient protection through availability of vaccination and post-
exposure prophylaxis.
• Training and education of health care workers to assure understanding of concepts in
disease transmission and methods of transmission.
REMEMBER: Whatever precautions may be taken, PROPER HAND HYGIENE---both
before and after patient care---is the MOST EFFECTIVE way to reduce the spread of
infection.
Work practice controls - methods of task performance which reduce or eliminate the risk of
exposure to infectious materials.
What practices and procedures are considered high risk for exposure to infectious body
fluids?
Percutaneous exposure to potentially infectious body fluid occurs through injury with a
contaminated sharp medical device such as a needle or scalpel.
The most recent data from hospitals participating in the CDC National Surveillance System for
Hospital Health Care Workers (NaSH) and from hospitals participating in the EPINet research
database show that hollow-bore needles, such as hypodermic needles and winged-steel
(butterfly-type) needles, account for nearly 62% of all percutaneous injuries. Suture needles
account for 21% of all percutaneous injuries.
The data demonstrated that the following activities are associated with an increased risk of injury
with a hollow-bore needle:
• Two-handed recapping.
• Transferring a body fluid between containers.
• Failure to properly dispose of used needles in puncture-resistant sharps containers.
• Manual disassembly of needle devices after they are used - e.g., pre-filled cartridge
syringes and phlebotomy needle/vacuum tube assemblies.
• Handling of needles attached to a length of flexible tubing - e.g., butterfly needles, and
needles attached to I.V. tubing.
• Insertion and withdrawal of needles from I.V. ports.
• Handling or passing a device during or after use.
Other causes of percutaneous exposure to infectious body fluids include injury with
contaminated suture needles especially while performing blind suturing; and injury with
contaminated broken glass tubes, bone spicules and metal fragments.
In addition to percutaneous injuries, health care workers can be exposed to potentially infectious
body fluids through contamination of mucous membranes or non-intact skin. Procedures that
generate aerosol sprays or splashing of fluid, such as irrigation or suctioning, can place the health
care worker at risk of exposure to potentially dangerous pathogens.
What engineering controls are available for reducing exposure to infectious body
fluids?
"Safe" needle systems and "needleless" systems.
Many manufacturers of syringes and devices that require the use of needles produce systems
with built-in safety features.
Examples include:
• syringes or scalpels with a sliding sheath that shields the attached needle or blade after
use;
These features are designed to reduce the risk of health care worker injury during and after
invasive procedures (e.g., blood drawing, injections). In addition, several manufacturers have
created systems which eliminate the use of needles for certain procedures, such as the
administration of intravenous fluids and medications through primary (e.g., heparin lock) and
secondary ports.
In November, 1999, the Occupational Safety and Health Administration (OSHA) issued a
revised compliance directive for the bloodborne pathogens standard. The revision now specifies
that "safer medical devices, such as sharps with engineered sharps injury protections and
needleless systems" constitute an effective engineering control, and must be used where feasible.
The standard is enforced directly by OSHA in several states. As of June 2002, twenty-one states
have enacted some type of legislation related to health care worker bloodborne pathogen
exposures. New York has enacted legislation based on the OSHA directive and enforcement is
managed by state or local agencies.
What work practice controls are effective for reducing exposure to airborne pathogens?
• Rapid identification of suspected cases
Rapid identification of disease will significantly reduce the risk of exposure to others. Clinicians
need to be aware of the airborne diseases (e.g., tuberculosis) which are prevalent in their
community and be able to recognize the symptoms and identify the populations at risk for such
diseases. With the potential use of airborne pathogens as part of bioterrorist activity, it is
imperative that health care providers be alert and responsive to patients who may have symptoms
of diseases commonly associated with this threat, such as smallpox or anthrax. Rapid
identification of airborne disease enables the timely initiation of appropriate therapy and the
prompt isolation of patients from all other susceptible individuals. Emergency rooms and clinics
should have triage procedures in place which allow for the identification of infectious patients at
the first point of contact with health care personnel.
• Isolation of potentially infectious individuals from others at risk.
The patient who is suspected of having an airborne infection should be immediately separated
from others at risk. In a hospital setting, the patient should be placed in an isolation room without
delay, if an assessment reveals the possibility of an airborne infection (e.g., tuberculosis, chicken
pox, measles or smallpox). Diagnostic tests which may confirm the presence of infection should
be performed while the patient is isolated.
If transport or movement is necessary, minimize patient dispersal of infectious droplet nuclei by:
(1) placing a surgical mask on the patient (if possible) and (2) covering the patient with a linen
sheet if a rash is present.
The patient should remain in isolation until either the presence of the disease is ruled out or until
the disease has progressed to a non-contagious state. In an ambulatory care setting, the patient
should be kept in a room away from others until either the patient is transferred to a hospital
(e.g., in the case of tuberculosis), or until the patient is sent home (e.g., in the case of a child with
chicken pox).
• Cover the mouth when coughing.
The global outbreak of SARS in 2003 emphasized the importance of preventing transmission of
respiratory infections at the first point of contact within a health care setting (e.g., reception and
triage areas in emergency departments, outpatient clinics, and physician offices).
Respiratory Hygiene / Cough Etiquette was incorporated into Standard Precautions as a
practical approach to reducing the risk of airborne transmission of infectious agents such as M.
tuberculosis bacilli, as well as pathogens transmitted via large respiratory droplets, such as
influenza virus, adenovirus, B. pertussis, N. meningitides and Mycoplasma pneumoniae.
Respiratory hygiene entails educating patients to cover their mouth when coughing or sneezing -
one of the most effective ways to control the spread of airborne pathogens. This simple practice
reduces the number of airborne bacterial or viral particles, thereby decreasing the risk of
transmission to patients and staff in the immediate area.
In common waiting areas, coughing persons should be encouraged to sit at least three feet away
from others if feasible.
Covering the mouth when coughing is particularly important when there is a delay in placing the
patient into an isolation room. Non-compliant patients should be fitted with a face mask until an
isolation room becomes available.
Health care facilities should ensure the availability of materials for adhering to respiratory
hygiene in waiting areas for patients and visitors. Tissues should be provided along with a no-
touch receptacle for disposal of contaminated tissues.
Patients and visitors should be instructed to perform hand hygiene after contact with respiratory
secretions. Dispensers of alcohol-based hand rub should be conveniently located. Where sinks
are available, ensure that supplies for hand washing (i.e., soap, disposable towels) are
consistently available.
SELECTION AND USE OF PERSONAL PROTECTIVE EQUIPMENT WHICH IS
DESIGNED TO PREVENT PATIENT & HEALTH-CARE WORKER CONTACT WITH
POTENTIALLY INFECTIOUS MATERIAL
Introduction
This section of the course provides information regarding the appropriate use of personal
protective equipment in the health care setting as a means of reducing exposure to infectious
pathogens.
Upon completion of this module, the learner will be able to:
• Recognize circumstances which call for the use of personal protective equipment in order
to prevent patient and health care worker contact with potentially infectious material;
• Identify specific personal equipment which is used to protect patients and health care
workers from exposure to infectious pathogens.
What is Personal Protective Equipment?
Personal protective equipment refers to specialized clothing and equipment worn by health care
providers for protection against hazards.
What types of personal protective equipment are available to health care workers and
when should this equipment be used?
There is a wide variety of protective equipment available to health care workers. The selection of
equipment for use in a specific situation is based upon the amount of contact the provider will
have with a patient's body fluids and/or mucous membranes.
GLOVES
Both sterile gloves and non-sterile gloves are available for use by health care workers.
Sterile surgical gloves are used for performing procedures which involve direct contact with
sterile body parts (e.g., surgical operations). Sterile gloves are also used when procedures are
performed which require the entry of sterile devices into sterile areas of the patient's body (e.g.,
cardiac catheterization, indwelling urinary catheter insertion, etc.). The use of sterile gloves is
required in order to reduce the risk of infection transmission to the patient.
Non-sterile examination gloves are used for performing procedures which may require contact
with a patient's body fluids, mucous membranes, or non-intact skin. Non-sterile utility gloves
should be used when decontaminating patient care equipment, when cleaning the patient care
environment, or when removing medical waste.
Most gloves made for use in the health care setting are constructed of latex.
Some gloves are made of vinyl or a similar polymer. Utility gloves are generally made of rubber.
Nitrile gloves are specifically designed for handling wet instruments which are disinfected with
glutaraldehyde solution.
Health care workers should be aware that gloves made of certain materials may cause allergic
reactions. If health care workers or patients are allergic to latex, hypo-allergenic gloves should be
used instead. Health care providers who are allergic to powder should use powderless gloves.
•
What types of cover garb are available?
Masks available for use by health care providers are classified as follows:
Non-surgical (or procedure) masks are fluid-resistant and have the capacity for relatively high
filtration of pathogenic organisms. Non-surgical and surgical masks have the same physical
appearance.
Surgical masks are lightweight and generally not fluid-resistant.
Particulate respirators are HEPA filtration masks which can screen out particles less than five
microns in size.
When should masks be worn?
Procedure masks should be worn whenever there is a risk of facial contamination with a
patient's body fluid. Facial contamination may occur during the performance of any procedure
which generates sprays or aerosols (e.g., dental procedures). Because most procedure masks have
a relatively high capacity for filtering most pathogenic organisms, they will provide respiratory
protection for the health care provider who is caring for a patient with an infection which may be
transmitted by infectious droplets, i.e., a patient on Droplet Precautions.
Surgical masks are lightweight but generally not fluid-resistant. Some surgeons prefer to use
surgical masks, in lieu of procedure masks, because they are more comfortable to wear over
extended periods of time. Fluid-resistant procedure masks are an appropriate alternative for
surgeons who desire maximum personal protection during the performance of surgical
procedures.
Particulate respirators are mandated under OSHA regulations for use by all health care
employees who enter rooms which house patients with known or suspected pulmonary
tuberculosis. Particulate respirators are also recommended for health care workers caring for
patients with known or suspected smallpox infection (if an outbreak should occur) and when
caring for patients with known or suspected SARS or Avian Influenza A (H5N1).
A complete guide for administering a Respirator Program is available through the National
Institutes of Occupational Safety and Health. This document is available on the Course
Reference page following completion of this course work.
GOGGLES AND FACE SHIELDS
The need for eye protection is often overlooked by many health care providers. However, it is
important to remember that infectious pathogens can enter the body through the eyes, just as they
can enter the body through the mucous membranes. For this reason, eye protection is very
important when encountering situations in which body fluid splashing may occur.
Goggles are simple and convenient to use. In addition, they provide greater protection than
ordinary eyeglasses. This is because goggles are designed with side pieces which cover all points
of entry to the eyes, while eyeglasses leave gaps on the sides through which fluids or aerosols
may enter.
Some face masks incorporate a
face shield into their design.
These composite devices are
convenient to use and offer
additional protection for health
care workers who perform
procedures which are likely to
generate body fluid splashing.
Face shields provide full
facial protection by means of a
transparent shield which
extends from the forehead to
the area just below the chin.
Shoe covers are recommended for use when performing procedures (e.g., orthopedic surgeries)
in which the health care provider's shoes are likely to become grossly contaminated by the
patient's body fluids. Since the risk of pathogen transmission from the surgeon's shoes to the
patient is relatively small, shoe covers are not regarded as important infection control barriers.
Their use in operating rooms is generally for aesthetic purposes, rather than for scientific ones. In
circumstances where there is a likelihood of gross contamination, fluid-resistant boots are a
better choice than shoe covers as they provide protection for the entire lower leg.
Head covers protect patients against pathogen transmission from the surgical team members' hair
during the course of an operation. Head covers are not regarded as a barrier to infection for
health care providers.
What are some general considerations for the selection and use of personal protective
equipment?
Impermeable barriers must be used whenever there is a potential for contact with large quantities
of blood or body fluids.
Barriers need not be used in situations where there is only casual patient contact.
Gloves should only be used when there is a potential for contact with body fluids, mucous
membranes, non-intact skin, or other contaminated items which may transmit infection.
Sterile barriers must be used when performing surgical procedures or invasive procedures (e.g.,
the insertion of intravascular monitoring devices).
Barriers should always be changed before beginning work on the next patient.
CREATION AND MAINTENANCE OF A SAFE ENVIRONMENT FOR PATIENT
CARE THROUGH THE APPLICATION OF INFECTION CONTROL PRINCIPLES
AND PRACTICES FOR CLEANING, DISINFECTION, AND STERILIZATION
Introduction
This section of the course provides information regarding the disinfection and sterilization of
patient care equipment and the maintenance of the patient care environment.
Cleaning is the most important step in the sterilization and disinfection process. Cleaning refers
to the removal of all foreign material (e.g., soil, organic material) from an object. There are
several important points to be made regarding the cleaning process:
• The presence of foreign material will protect microbes from exposure to disinfectants and
sterilants.
• Cleaning should be performed immediately after the item is used to prevent foreign
material from drying and adhering to the instrument.
• Physical cleaning eliminates large numbers of microbes, thereby increasing the efficiency
of the disinfection and sterilization process.
• The presence of organic matter may inhibit the ability of disinfectant solution to
eliminate microorganisms.
• Residual detergent from cleaning may inactivate the disinfectant; therefore rinsing is
important.
Dirt is not sterile. An item cannot be considered sterile if it has body substances encrusted
onto it, even if the item has gone through a sterilization process.
Can the cleaning process be automated?
Automated cleaning will effectively remove foreign material (e.g., organic material, soil) from
patient care equipment. In addition, automated cleaning reduces the transmission of potentially
infectious body fluids to personnel who are responsible for processing contaminated instruments.
Common tools for automated cleaning include:
Washer-sterilizer - mechanically agitates a detergent bath in which an item is immersed. The
item is usually put through a steam heat cycle which sterilizes its surface areas.
Ultrasonic cleaner - produces sonic waves which generate minute bubbles from gas nuclei. The
bubbles implode, thereby dissolving foreign material from surfaces.
Washer-decontaminators or Washer-disinfectors – act like a dishwasher and use a
combination of water circulation and detergent to remove soil. They are very effective in
removing and inactivating microorganisms from instruments. Washer-disinfectors are generally
computer-controlled units for cleaning, disinfecting, and drying solid and hollow surgical and
medical equipment.
How can health care professionals select the appropriate method of sterilization or
disinfection for reprocessing specific patient care items?
There are basic guidelines that can assist health care providers in making decisions regarding the
appropriate level of disinfection or sterilization.
Health professionals who are responsible for reprocessing instruments should always consult the
manufacturer's guidelines for instructions regarding the proper method of cleaning, disinfection
or sterilization. Many instruments, such as endoscopes, are constructed with delicate parts (e.g.,
camera lenses) which may be damaged by disinfectant solutions or inappropriate sterilization
processes.
E.H. Spaulding developed a "rational approach to sterilization and disinfection". According to
Spaulding, the appropriate method of sterilization or disinfection becomes clear when patient
care items are classified into one of three categories.
1. Critical items
Critical items are instruments or equipment which come into contact with sterile tissue or the
vascular system. If they are contaminated with any microorganisms, critical items will pose a
high risk of infection to the patient. Therefore, critical items must be kept sterile.
Examples of critical items include the following:
• urinary catheters
• needles and syringes
• orthopedic implants
• cardiac catheters
• scalpels
• surgical instruments
Single-use disposable sterile items must be stored in a manner to maintain integrity of the
manufacturer’s packaging. Non-disposable items (e.g., surgical instruments) must be cleaned and
undergo appropriate sterilization before they can be re-used.
2. Semi-critical items
Semi-critical items are instruments or equipment which come into contact with mucous
membranes or with non-intact skin. These items must be kept free of all microorganisms except
for small numbers of bacterial spores.
Since the body's mucous membranes can resist infection from small numbers of bacterial spores,
their presence does not pose a risk of infection.
Semi-critical items generally require high-level disinfection.
Examples of semi-critical items include the following:
• respiratory therapy equipment
• anesthesia equipment
• endoscopes
3. Non-critical items
Non-critical items refer to equipment which comes into contact with intact skin but not with
mucous membranes. Since intact skin acts as an effective barrier to most microorganisms,
sterility is not critical. Intermediate-level and low-level disinfection of non-critical items is
acceptable.
Examples of noncritical items include the following:
• blood pressure cuffs
• crutches
• patient furniture
Steam under pressure is the preferred method for sterilizing for instruments that are stable in
the presence of heat and moisture such as stainless steel surgical instruments.
Ethylene oxide, hydrogen peroxide gas plasma and ozone are appropriate for devices that may
be damaged by heat and moisture, such as cameras and lensed instruments.
Liquid chemicals – i.e., peracetic acid, high-concentration hydrogen peroxide, and
glutaraldehyde – are appropriate for devices that can tolerate moisture but not high temperatures.
Dry heat is appropriate for sterilization of anhydrous oils, petrolatum products, and powders;
however, since the majority of these products are provided sterile by commercial manufacturers,
dry heat is rarely used in medical facilities.
For those health professionals who have direct or indirect involvement in instrument processing,
it is recommended that Table 5-2 be closely reviewed.
The following table provides detailed information about methods of sterilization:
Table 5-2: Methods of Sterilization
Under vacuum, water Ozone gas sterilization Advantages: safe to use and
vaporizes at room environmentally friendly;
temperature. Oxygen non-corrosive to metals and
is subjected to an effective for reprocessing of
electrical discharge, metals, glass, ceramics,
breaks down into silica, plastics and
monatomic oxygen elastomers; no aeration time
and then re-forms as or cool-down time is
ozone (O3). Contents required; requires only
Ozone are sterilized through appropriate steam and water
oxidation. Ozone quality, oxygen gas and
then reverts to electricity.
oxygen and is vented Disadvantages: limited use
into the room along -- the system is not intended
with low humidity for use in processing any
water vapor. flexible endoscopes, glass or
plastic ampoules, liquids or
implants; small chamber.
The following table describes recommended methods for monitoring the sterilization
process:
METHOD OF
REQUIRED MONITORING PROCESS
STERILIZATION
Mechanical indicators: maintain charts which record time and temperature; pressure
gauge readings. Required with every load.
Ozone Chemical indicators: specific to ozone gas.
Biological indicators: Geobacillus stearothermophilus spore testing.
Instruments that are being prepared for sterilization must be scrupulously cleaned and
appropriately wrapped and packaged prior to and/or after undergoing sterilization. The
sterilizer’s manufacturer should be consulted regarding the appropriate packaging materials to
use. Liquid chemical sterilization does not allow for the pre-packaging of items. Hence, great
care must be taken following the sterilization process to ensure that instruments do not become
re-contaminated.
How should sterile items be stored?
Sterile items should be stored in closed cabinets in a limited access area. The area should be
clean, dry, and dust-free with a temperature of 65 - 72 degrees F and a relative humidity of 35 -
50%. Packages should be kept on clean shelves that are 8 - 10 inches above the floor, 18 - 20
inches below the ceiling, and 6 - 8 inches from the wall.
How long will instruments remain sterile following adequate re-processing?
Event-Related Sterility is a practice currently recommended by numerous professional
associations including the Association of Operating Room Nurses. If an instrument is stringently
re-processed, it will remain sterile until some event causes the item to become contaminated
(e.g., tear in the packaging, packaging becoming wet, etc). Packages should be closely inspected,
prior to opening, to ensure that integrity has remained intact. Instruments should not be used if
there is any evidence of damage to the packaging. Expiration dates are only needed to ensure
proper inventory turnover or to indicate expiration of some component of the pack (e.g., skin
preparation solution).
What are the most common methods of disinfection?
Semi-critical patient care items require high level disinfection which is most commonly achieved
through the use of liquid chemicals. Pasteurization (i.e., high level disinfection with hot water)
may be used to disinfect equipment which can tolerate heat and water such as anesthesia
equipment and respiratory therapy equipment.
The most common high level disinfectant solutions available today are:
• Glutaraldehyde: 2% or greater concentration
• Ortho-phtalaldehyde: 0.55% concentration
• Hydrogen peroxide: 7.5% concentration
• Combined hydrogen peroxide and peracetic acid in various concentrations
• Hypochlorite (free chlorine) in a concentration of 650-675 ppm
Some of these chemical solutions can also be used to achieve sterilization. The chemical’s
product label is the best place to find information regarding the appropriate soak time and
temperature necessary to achieve high level disinfection or sterilization. It will also provide a
listing of the infectious pathogens against which the chemical is active. Before soaking
instruments in these chemicals, the instruments must be scrupulously cleaned in order to remove
all organic matter.
For those practitioners involved directly or indirectly with reprocessing instruments used on
patients, the following table provides information regarding the advantages and disadvantages of
the various liquid chemicals available to achieve high level disinfection / sterilization:
The following table provides information regarding the advantages and disadvantages of
using liquid chemicals to achieve high-level disinfection / sterilization:
These solutions must be routinely monitored with manufacturer-specific test strips to assure
that the chemical solution is at the proper concentration to achieve high level disinfection or
sterilization. If a test strip determines sub-optimal concentration, the solution must be discarded.
In addition, these solutions have very specific expiration dates and must be discarded when
expired. A solution at sub-optimal concentration must be discarded regardless of expiration date.
In general, when using any chemical disinfectant:
• Read the label for activity and use instructions.
• All items must be thoroughly cleaned before disinfecting.
• All items must be thoroughly rinsed and dried after disinfecting. Care must be taken to
avoid re-contaminating items.
• Only surfaces in direct contact with the solution will be disinfected. Instruments must be
opened, disassembled, and completely submerged for the required period of time in order
to achieve disinfection.
• Items should be dry before submerging to avoid diluting the solution to inactive levels.
• Gloves should be worn to protect the skin. The use of goggles may be advisable to
protect the eyes from fluid splashes.
What disinfectants are appropriate for non-critical patient equipment and sanitizing the
patient care environment?
Intermediate and low level disinfection is appropriate for non-critical patient care equipment and
for sanitizing the patient care environment. The chemical’s product label should be consulted for
specific instructions regarding proper use. The product label will also identify the specific
pathogens which will be eliminated by the chemical.
The following table provides detailed information about the use of chemicals for
intermediate and low-level disinfection:
Non-critical patient care equipment should be cleaned with an appropriate disinfectant solution
which remains in contact with the item for at least 1 minute. Any non-critical equipment that is
used in the care of a patient on Contact Precautions should be disinfected before being used on
another patient.
Are there any special considerations for disinfection with emerging pathogens like MRSA
or Clostridium difficile?
The standard sterilization and disinfection practices covered in this element are adequate to
process instruments or devices contaminated with blood and other body fluids from persons
infected with emerging pathogens.
In instances where clusters of patients are found to be infected with Clostridium difficile or
norovirus, environmental surfaces should be cleaned with a disinfectant known to be active
against these agents – e.g., hypochlorite (bleach) solution in a 1:10 dilution. The manufacturer’s
label on the container of the disinfectant solution will contain specific information regarding
pathogens against which the chemical content is active.
With the advent of computerization in health care settings, computer keyboards used by multiple
staff members have the ability to become a potential object of “touch” contamination in patient
areas. Keyboards should be disinfected daily for 5 seconds and when visibly soiled. One study
showed that commercial disinfecting wipes (Clorox and Metrex) were effective at removing 95%
of bacteria from the keyboard (without any cosmetic damage after 300 wipes) and had a residual
anti-bacterial effect for 48 hours.
Glucose monitoring devices or glucometers are commonly used in many inpatient and outpatient
settings. In 2005, the Centers for Disease Control reported the findings of three outbreaks of
Hepatitis B virus (HBV) among patients in long term care facilities. Transmission of the virus
was associated with contaminated glucose monitoring devices. Patients should be assigned
separate glucometers. If a glucometer is to be used on another patient, the exterior surface of the
device should be disinfected with a solution that is capable of eliminating HIV and HBV virus
and is active against tuberculosis, or a dilute solution of bleach (1:10 – 1:100 concentration).
Alcohol is not recommended as it will damage the LED readout of the glucometer and
quarternary ammonium solutions may damage metal parts. Single use lancets that permanently
retract upon piercing the skin are preferred.
The United States Environmental Protection Agency maintains an online listing of registered
antimicrobial products effective against certain blood borne/body fluid pathogens, Mycobacteria
tuberculosis (tubercle bacteria), human HIV-1 virus, Hepatitis B, Hepatitis C viruses, as well as
products classified as sterilizers. There are also products registered as effective against
Methicillin Resistant Staphylococcus aureus (MRSA), Vancomycin Resistant Enterococcus
faecalis or faecium (VRE), human Norovirus (Norwalk like Virus), as well as products used for
medical waste treatments in health care/medical facilities. The EPA website is www.epa.gov.
Measles, Mumps, Rubella (MMR): All persons who work in health care facilities are required
to be immune to measles and rubella according to New York State regulations. It is also
recommended that the worker be immune to mumps. Health care workers can undergo laboratory
testing to verify immunity or provide documentation evidencing prior vaccination for these
diseases.
Diphtheria, Pertussis, Tetanus: It is recommended that all health care workers be vaccinated
with one dose of Tdap (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis) to
protect themselves, their patients, other health care staff, family members and the community
against tetanus, diphtheria, and pertussis. After initial vaccination, adults require a tetanus
booster shot (0.5 ml) every ten years to ensure immunity. Health care personnel who have direct
patient contact should receive a single dose of Tdap vaccine in lieu of the standard tetanus and
diphtheria (Td) booster and can do so as little as two years after their last Td shot.
Hepatitis B Vaccine: Any person who performs tasks involving contact with blood, blood-
contaminated body fluids, or sharps should be vaccinated against hepatitis B. According to the
OSHA Bloodborne Pathogen Standard, employers are required to offer Hepatitis B vaccine, at no
charge, to health care workers who are at risk for occupational exposure to blood or body fluids
that contain blood. If vaccination is refused, employees are required to sign a statement
confirming their understanding of the potential consequences. Such employees may still request
vaccination at a future date during their employment.
Influenza Vaccine: Influenza can be a severely debilitating and sometimes deadly disease. The
standard of care in New York State is that all health care workers should receive an annual
influenza vaccination. In addition, Public Health Law Article 21A, the Long-term Care Resident
and Employee Immunization Act, requires that all long-term care facilities, adult homes, adult
day health care facilities, and enriched housing programs offer influenza vaccine to all
employees and residents. It is generally offered free of charge to employees at large health
facilities. If not provided by the employer, influenza vaccine may be obtained at little expense.
Varicella Vaccine: It is recommended that all health care workers be immune to varicella.
Evidence of immunity includes documentation of 2 doses of varicella vaccine given at least 28
days apart; a document evidencing history of varicella disease (chickenpox) or herpes zoster
based on physician diagnosis; or laboratory documentation showing immunity or confirmation of
disease.
The references associated with this module will provide additional information on vaccination
requirements for health care workers. These references will be available on the Course Reference
page accessible from your Student Control Panel following completion of this course.
For which diseases should prophylaxis be considered if a health care worker is exposed?
For certain diseases, there is post-exposure prophylactic treatment available to prevent the
development of fully symptomatic disease.
The following table provides detailed information regarding the available treatments for specific
diseases:
Hepatitis C (HCV)
Hepatitis C virus (HCV) is not transmitted efficiently through occupational exposure to blood.
The risk of seroconversion (positive HCV antibody test) following accidental percutaneous
exposure to a known HCV-positive source is 1.8%. There have been no documented cases of
transmission to a health care worker following intact or non-intact skin exposures to blood.
There is currently no recommended post-exposure prophylactic treatment for Hepatitis C.
Following health care worker exposure, the source patient should be tested for Hepatitis C
antibodies (anti-HCV). The exposed worker should receive baseline testing for Hepatitis C
antibodies (anti-HCV) and alanine aminotransferase levels (ALT).
If the source patient is found to have Hepatitis C antibodies, there is a risk of HCV transmission
to the exposed health care worker. The mean incubation period from transmission of HCV
infection to the onset of symptoms is 6-7 weeks (range: 2-26 weeks); however, only 20-30% of
newly infected persons are symptomatic. Serum ALT levels increase 4-12 weeks after acute
HCV infection. Antibodies to HCV (anti-HCV) may or may not be present when symptoms
develop or with elevations in ALT levels; however, after 3 months of HCV infection, anti-HCV
is detectable by immunoassay in 90% of infected persons. An exposed worker should receive
follow-up testing which may include: (1) nucleic acid test for HCV RNA immediately after
exposure, at week 4 and at week 12; (2) anti-HCV by EIA or CIA immediately after exposure
and at week 12; and (3) serum ALT and AST immediately after exposure, at week 4 and at week
12.
When HCV infection is identified early, the health care worker should be referred for medical
management to a specialist knowledgeable in this area.
There have been substantial improvements in the success of HCV treatment and there are
currently several treatments approved by the FDA. Combination therapy, using pegylated
interferon and ribavirin, is currently the treatment of choice. Combination therapy can eliminate
the virus in about 5 out of 10 persons for genotype 1 (predominant in the U.S.) and in up to 8 out
of 10 persons for genotype 2 and 3.
Hepatitis B (HBV)
The risk of Hepatitis B transmission is correlated with both the degree of contact with blood and
the hepatitis B "e" antigen (HBeAg) status of the source person. In studies of susceptible health
care personnel who sustained injuries from needles contaminated with blood containing HBV,
the risk of developing clinical hepatitis was 22% - 31% if the source blood was positive for
HBeAg. By comparison, the risk of developing clinical hepatitis was only 1% - 6% if HBeAg
was negative.
Percutaneous injuries, such as needle sticks, are among the most efficient modes of HBV
transmission. However, these types of exposures only account for a minority of HBV infections
among health care workers. Research has shown that most infected health care personnel do not
recall an overt exposure such as a percutaneous injury. Also, it is important to recognize that
HBV has been demonstrated to survive in dried blood at room temperature on environmental
surfaces for at least one week. Thus, HBV infections that occur in persons with no history of
exposure may result from contact with contaminated environmental surfaces.
Unlike Hepatitis C, there are recommended prophylactic treatments available to health care
workers who may have been exposed to Hepatitis B (i.e., Immune Globulin, vaccine).
The Centers for Disease Control (CDC) has published recommendations for post-exposure
evaluation and treatment of health care workers following potential exposure to Hepatitis B
which are summarized in the following table:
The following table summarizes CDC recommendations for post-exposure prophylaxis for
Hepatitis B:
Administer HB Immune
Initiate HB
Globulin (HBIG) x 1 dose Initiate HB vaccine
Unvaccinated and initiate HB vaccine
vaccine
series.
series.
series.
Previously
vaccinated: Known No treatment. No treatment. No treatment.
responder*
* Responder is defined as a person with adequate levels of serum antibody to Hepatitis B antigen (i.e., anti-HBs
>/= 10 mIU/mL)
** Non-responder is defined as a person with inadequate levels of serum antibody to Hepatitis B antigen (i.e.,
anti-HBs < 10 mIU/mL)
***The option of giving one dose HBIG and reinitiating the vaccine series is preferred for non-responders who
have not completed a second 3-dose vaccine series. For persons who previously completed a second vaccine series
but failed to respond, two doses of HBIG are preferred.
What is the risk of acquiring HIV infection following exposure to known HIV-infected
blood?
The risk of acquiring HIV, following occupational exposure, is currently estimated as follows:
• Exposure from needlestick or cut - Risk is 0.3% (approximately 1 in 300).
• Exposure to eye, nose, or mouth - Risk is 0.09% (approximately 1 in 1,000).
• Exposure to non-intact skin - Risk is less than 1 in 1,000
Risk may be increased if:
• Exposure involved a deep injury to the health care worker.
• Blood is visible on the device which caused the injury.
• The device had been placed in the source patient's vein or artery.
• The source patient is in the terminal stages of AIDS.
What are the current recommendations for post-exposure prophylaxis for HIV?
The Centers for Disease Control and Prevention maintains a comprehensive set of guidelines for
post-exposure management of occupational exposures to HIV. These guidelines were last
updated in September, 2005, and are widely practiced throughout the United States. The New
York State Department of Health AIDS Institute, in cooperation with the Johns Hopkins
University Division of Infectious Diseases, has developed a modified set of guidelines for
statewide implementation which represent a more aggressive approach to blocking HIV infection
following occupational exposure. The post-exposure treatment specified in the New York State
guidelines is known as HAART – highly active antiretroviral therapy – and consists of a three
drug regimen. The post-exposure regimens recommended by the CDC consist of two drugs
(basic) or three or more drugs (expanded) depending on the type and severity of exposure
sustained by the health care worker.
General considerations following an exposure are as follows:
Wound and skin sites should be cleansed with soap and water immediately. Exposed mucous
membranes should be flushed with water.
Post-exposure prophylaxis (PEP) is recommended for exposure to blood or visibly bloody fluid
or other potentially infectious material (e.g., semen, vaginal secretions, and cerebrospinal,
synovial, pleural, peritoneal, pericardial, and amniotic fluids) associated with potential HIV
transmission and in any of the following exposure situations:
• Break in the skin by a sharp object (including both hollow-bore and cutting needles or
broken glassware) that is contaminated with blood, visibly bloody fluid, or other
potentially infectious material, or that has been in the source patient’s blood vessel.
• Bite from an HIV-infected patient with visible bleeding in the mouth that causes bleeding
in the health care worker.
• Splash of blood, visibly bloody fluid, or other potentially infectious material to a mucosal
surface (mouth, nose, or eyes).
• A non-intact skin (e.g., dermatitis, chapped skin, abrasion, or open wound) exposure to
blood, visibly bloody fluid, or other potentially infectious material.
If HIV serostatus of the source is unknown, voluntary HIV testing of the source should be
sought. If rapid blood testing is available on site, it should be used to determine the HIV status of
the source patient as results are usually available within 30 minutes. Rules regarding
confidentiality and consent for rapid testing are identical to those for other HIV tests. In New
York State, specific informed consent for HIV testing is required.
If the preliminary rapid test result is positive, the result should be given to the source patient. To
establish a diagnosis of HIV infection, the test must be confirmed by a Western blot assay, which
should be performed as soon as possible. If the result from testing the source patient is not
immediately available and PEP is indicated based on assessment, the initiation of PEP should not
be delayed pending the test result.
PEP should be initiated as soon as possible, ideally within 2 hours and generally no later
than 36 hours post-exposure. The prescribing provider should ensure that the exposed
worker has access to the full course of prophylactic antiretroviral medications.
Medications for PEP should be readily available to all workers. Employers should have a plan in
place which specifies the following:
• A procedure for providing PEP within 1 to 2 hours of an exposure.
• Location of a 24- to 48-hour supply of PEP for urgent use.
• A designated person with the authority for releasing drugs for PEP.
• A means by which a worker will obtain PEP drugs to complete the 4-week regimen
(some individuals may be reluctant to go to their local pharmacy)
• A mechanism for confidential baseline HIV antibody testing of the worker at the time the
occupational exposure is reported or within 72 hours of initiating PEP, and confidential
HIV testing of the source as soon as possible after the exposure.
If the source patient's HIV test result is negative, the health care worker should be informed of
the small chance that it could be a false-negative result if the source patient has been recently
infected. PEP should be recommended in situations when a significant risk exposure has
occurred and the clinician suspects that the source patient has a strong likelihood of having
recently acquired HIV infection.
If a recommendation to begin PEP is declined, this decision should be documented in the
medical record of the exposed worker.
All persons placed on PEP should be re-evaluated within 72 hours of their exposure. This allows
for further clarification of the nature of the exposure, review of available source patient
serologies, and evaluation of adherence to and toxicities associated with the PEP regimen.
A total of 4 weeks of treatment is recommended. This treatment duration is based on animal data
and is generally recommended by HIV Specialists.
As of January, 2008, the following PEP is recommended in New York State:
Zidovudine 300 mg PO bid + Lamivudine 150 mg PO bid (or Combivir 1 PO bid)
Plus Tenofovir 300 mg PO qd
OR
Zidovudine 300 mg PO bid
Plus Emtricitabine 200 mg PO qd + Tenofovir 300 mg PO qd (or Truvada 1 PO qd)
An HIV Specialist or an occupational health clinician experienced in providing PEP should be
consulted if there is any question about managing an exposure. Resources available for telephone
or in-person consultation can be found on the New York State Department of Health AIDS
Institute web site at www.hivguidelines.org. In addition, the National AIDS/HIV Clinicians’
Consultation Center is available for PEP guidance at 1-888-448-4911.